Description
Tradename:
Somazina
Compound:
Each ml of suspension contains:
Citicoline 100 mg
Properties:
Nootropic drug. Citicoline, being a precursor of key ultrastructural components of the cell membrane (mainly phospholipids), has a wide spectrum of action: it promotes the restoration of damaged cell membranes, inhibits the action of phospholipases, preventing the excessive formation of free radicals, and also prevents cell death by affecting the mechanisms of apoptosis.
In the acute period of stroke, citicoline reduces the volume of brain tissue damage and improves cholinergic transmission.
In case of traumatic brain injury, it reduces the duration of post-traumatic coma and the severity of neurological symptoms; in addition, citicoline helps to reduce the duration of the recovery period.
In chronic cerebral hypoxia, citicoline is effective in the treatment of cognitive disorders such as memory impairment, lack of initiative, and difficulties in performing daily activities and self-care. Increases the level of attention and consciousness, and also reduces the manifestation of amnesia.
Indications:
-acute period of ischemic stroke (as part of complex therapy);
-recovery period of ischemic and hemorrhagic strokes;
– traumatic brain injury, acute (as part of complex therapy) and recovery period;
-cognitive and behavioral disorders in degenerative and vascular diseases of the brain.
Directions for use and dosage:
In case of cognitive impairment:
Adults: 500-1000 mg per day for 3 months.
Children: 500-750 mg per day for 3 months.
In the case of acute and subacute cerebrovascular accidents and when the patient can swallow:
Adults: 500-2000 mg per day for 6 weeks.
Children: 500-750 mg per day for 6 weeks.
Contraindications:
– pronounced vagotonia (predominance of the tone of the parasympathetic part of the autonomic nervous system);
-rare hereditary diseases associated with fructose intolerance;
– hypersensitivity to the components of the drug.
Precautionary measures:
During the treatment period, patients should be careful when performing potentially hazardous activities that require special attention and speed of psychomotor reactions (including driving a car and other vehicles, working with moving mechanisms, working as a dispatcher and operator).
Side effects:
Very rare (<1/10,000) (including individual cases): allergic reactions (rash, itching, anaphylactic shock), headache, dizziness, feeling hot, tremor, nausea, vomiting, diarrhea, hallucinations, swelling, shortness of breath, insomnia , agitation, loss of appetite, numbness in paralyzed limbs, changes in the activity of liver enzymes. In some cases, Ceraxon® can stimulate the parasympathetic system and also cause a short-term change in blood pressure.
Storage method:
At a temperature not higher than 25 degrees.
